Consolidated Statements of Changes in Equity - CAD ($) $ in Millions |
Total |
Issued capital [member]
Preferred shares and other equity instruments [member]
|
Issued capital [member]
Common shares [member]
|
Treasury instruments [member]
Preferred shares and other equity instruments [member]
|
Treasury instruments [member]
Common shares [member]
|
Retained earnings [member] |
Other components of equity [member] |
Equity attributable to shareholders [member] |
Non-controlling interests [member] |
FVOCI securities and loans [member]
Other components of equity [member]
|
Foreign currency translation reserve [member]
Other components of equity [member]
|
Cash flow hedge reserve [member]
Other components of equity [member]
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at beginning of period at Oct. 31, 2020 | $ 86,767 | $ 5,948 | $ 17,628 | $ (3) | $ (129) | $ 59,806 | $ 3,414 | $ 86,664 | $ 103 | $ (139) | $ 4,632 | $ (1,079) |
Changes in equity | ||||||||||||
Issues of share capital and other equity instruments | 2,345 | 2,250 | 100 | (5) | 2,345 | |||||||
Redemption of preferred shares and other equity instruments | (1,475) | (1,475) | (1,475) | |||||||||
Sales of treasury shares and other equity instruments | 4,763 | 647 | 4,116 | 4,763 | ||||||||
Purchases of treasury shares and other equity instruments | (4,743) | (683) | (4,060) | (4,743) | ||||||||
Share-based compensation awards | (6) | (6) | (6) | |||||||||
Dividends on common shares | (6,158) | (6,158) | (6,158) | |||||||||
Dividends on preferred shares and distributions on other equity instruments | (260) | (257) | (257) | (3) | ||||||||
Other | 23 | 33 | 33 | (10) | ||||||||
Net income | 16,050 | 16,038 | 16,038 | 12 | ||||||||
Total other comprehensive income (loss), net of taxes | 1,456 | 2,344 | (881) | 1,463 | (7) | 51 | (2,577) | 1,645 | ||||
Balance at end of period at Oct. 31, 2021 | 98,762 | 6,723 | 17,728 | (39) | (73) | 71,795 | 2,533 | 98,667 | 95 | (88) | 2,055 | 566 |
Changes in equity | ||||||||||||
Issues of share capital and other equity instruments | 848 | 750 | 99 | (1) | 848 | |||||||
Common shares purchased for cancellation | (5,426) | (509) | (4,917) | (5,426) | ||||||||
Redemption of preferred shares and other equity instruments | (155) | (150) | (5) | (155) | ||||||||
Sales of treasury shares and other equity instruments | 5,474 | 552 | 4,922 | 5,474 | ||||||||
Purchases of treasury shares and other equity instruments | (5,701) | (518) | (5,183) | (5,701) | ||||||||
Share-based compensation awards | 2 | 2 | 2 | |||||||||
Dividends on common shares | (6,946) | (6,946) | (6,946) | |||||||||
Dividends on preferred shares and distributions on other equity instruments | (252) | (247) | (247) | (5) | ||||||||
Other | (56) | (56) | (56) | |||||||||
Net income | 15,807 | 15,794 | 15,794 | 13 | ||||||||
Total other comprehensive income (loss), net of taxes | 5,818 | 2,618 | 3,192 | 5,810 | 8 | (2,269) | 3,633 | 1,828 | ||||
Balance at end of period at Oct. 31, 2022 | $ 108,175 | $ 7,323 | $ 17,318 | $ (5) | $ (334) | $ 78,037 | $ 5,725 | $ 108,064 | $ 111 | $ (2,357) | $ 5,688 | $ 2,394 |